Welcome : Guest

Alcobra Ltd. (Israel) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Alcobra Ltd., which is principally involved in Biopharmaceuticals Business. Illustrated with 9 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-63680
Price: $450
Company Type: Public
Pages: 10
Date: November 2016
Market Data Tables: 9

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Central Nervous System (CNS) Drugs......2
Table 1: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......2
Table 2: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......3
Neurology......4
Table 3: Neurology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cerebrospinal Fluid Management, Interventional Neuroradiology, Neurostimulation, Neurosurgery, and Neurovascular Catheters......4
Non-Stimulant......5
Table 4: Non-Stimulant Drugs Market by Prescription Worldwide (2015) - Percentage Share Breakdown by Value for Intunniv, Kapvay, and Strattera......5
Pediatric Non-Stimulant Drugs......6
Table 5: Pediatric Non-Stimulant Drugs Market by Prescription Worldwide (2015) - Percentage Share Breakdown by Value Sales for Intunniv, Kapvay, and Strattera......6
Adult Non-Stimulant......7
Table 6: Adult Non-Stimulant Drugs Market by Prescription Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kapvay, and Strattera......7
Central Nervous System (CNS) Medicines......8
Table 7: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......8
Table 8: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......9
Attention Deficit Hyperactivity Disorder (ADHD)......10
Table 9: Market Shares of Leading Drugs for Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the US (2015) - Percentage Share Breakdown by Value for Intuniv, Strattera and Others......10